Amanote Research
Register
Sign In
Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin
Leukemia
- United Kingdom
doi 10.1038/leu.2008.89
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
April 17, 2008
Authors
L X Wu
J H Xu
K Z Zhang
Q Lin
X W Huang
C X Wen
Y Z Chen
Publisher
Springer Science and Business Media LLC
Related search
Retraction Note: Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
MT1-MMP as a Downstream Target of BCR-ABL/ABL Interactor 1 Signaling: Polarized Distribution and Involvement in BCR-ABL-stimulated Leukemic Cell Migration
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
BCR-ABL-transformed GMP as Myeloid Leukemic Stem Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
BCR-ABL Tyrosine Kinase
Science-Business eXchange
Bcr: A Negative Regulator of the BCR-Abl Oncoprotein in Leukemia
Oncogene
Cancer Research
Genetics
Molecular Biology
SRC Family Kinases Phosphorylate the BCR-Abl SH3-SH2 Region and Modulate BCR-Abl Transforming Activity
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Development of a Potent Protein Degrader Against Oncogenic BCR-ABL Protein
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia
Haematologica
Hematology
